Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Libi Labs, Inc.
WARNING LETTER
•Libi Labs, Inc.•April 1, 2013

Libi Labs, Inc. – FDA Warning Letter, Apr 1, 2013

Record Details

The FDA inspected Libi Labs, Inc.'s dietary supplement manufacturing facility in Largo, FL, from March 25 to April 1, 2013, identifying significant violations of Current Good Manufacturing Practice (CGMP) regulations for dietary supplements (21 CFR Part 111). These violations render the firm's Green Coffee Bean Capsules and Weightloss Supplement Capsules adulterated under section 402(g)(1) of the Federal Food, Drug and Cosmetic Act. Key violations include the failure to conduct identity testing for dietary ingredient components (21 CFR 111.75(a)(1)(i)), failure to qualify suppliers by confirming the reliability of their Certificates of Analysis (21 CFR 111.75(a)(2)(ii)(A)), and failure to establish component specifications (21 CFR 111.70(b)). Additionally, the firm failed to establish in-process specifications (21 CFR 111.70(c)(1)) and did not prepare or follow written Master Manufacturing Records (MMRs) for each unique formulation and batch size (21 CFR 111.205(a)). Libi Labs' written responses from April and July 2013 were deemed inadequate, as they lacked sufficient documentation to demonstrate corrective actions or actual compliance with CGMP requirements. The FDA emphasized the firm's responsibility for ensuring product quality and compliance. The company must promptly correct all cited violations and respond within fifteen working days with specific corrective steps and supporting documentation. Failure to comply may lead to legal action, including seizure and injunction, and potential re-inspection fees. The letter also noted the need for stability data to support any expiration dates.

Company
Libi Labs, Inc.
Inspection date
April 1, 2013
Product type
Food
Office
Florida District Office
People
  • Kathleen M. Sinninger
  • Randall L. Morris (Compliance Officer)
View Company Profile

ID · 4f4f0afb-263a-444b-914b-1b226a1bd05d

Violation Codes9
21 CFR 11121 U.S.C. 342(g)(1)21 CFR 111.75(a)(1)(i)21 CFR 111.75(a)(2)(ii)(A)21 CFR 111.70(b)21 CFR 111.70(c)(1)21 CFR 111.205(a)21 CFR 111.21021 U.S.C. 379j-31

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Libi Labs, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.